These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 23838753)
1. Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial. Phan TG; Demchuk A; Srikanth V; Silver B; Patel SC; Barber PA; Levine SR; Hill MD Cerebrovasc Dis; 2013; 35(6):560-5. PubMed ID: 23838753 [TBL] [Abstract][Full Text] [Related]
2. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry. Nezu T; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Kario K; Naganuma M; Maeda K; Minematsu K; Toyoda K Stroke; 2011 Aug; 42(8):2196-200. PubMed ID: 21719764 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke. Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558 [TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke. Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603 [TBL] [Abstract][Full Text] [Related]
5. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977 [TBL] [Abstract][Full Text] [Related]
6. Repeated-measures analysis of the National Institute of Neurological Disorders and Stroke rt-PA stroke trial. Feng W; Vasquez G; Suri MF; Lakshminarayan K; Qureshi AI J Stroke Cerebrovasc Dis; 2011; 20(3):241-6. PubMed ID: 20621509 [TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation. Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111 [TBL] [Abstract][Full Text] [Related]
8. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial. Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722 [TBL] [Abstract][Full Text] [Related]
9. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy]. Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535 [TBL] [Abstract][Full Text] [Related]
10. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience. Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226 [TBL] [Abstract][Full Text] [Related]
11. The Combination of Clinical Features, Transcranial Doppler, and Alberta Stroke Program Early Computed Tomography Score (Computed Tomography Angiography) in Predicting Outcome in Intravenous Recombinant Tissue Plasminogen Activator-Treated Patients. Saqqur M; Ghrooda E; Ahmad A; Khan K; Hussain MS; Shuaib A J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2019-23. PubMed ID: 27241578 [TBL] [Abstract][Full Text] [Related]
12. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. IMS Study Investigators Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018 [TBL] [Abstract][Full Text] [Related]
13. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333 [TBL] [Abstract][Full Text] [Related]
14. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke. Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742 [TBL] [Abstract][Full Text] [Related]
16. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Hong KS; Saver JL Stroke; 2010 Mar; 41(3):471-7. PubMed ID: 20133917 [TBL] [Abstract][Full Text] [Related]
17. Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trials Exploratory Analysis. Balucani C; Levine SR; Khoury JC; Khatri P; Saver JL; Broderick JP J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):894-901. PubMed ID: 26825352 [TBL] [Abstract][Full Text] [Related]
19. Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database. Nagel S; Wang X; Carcel C; Robinson T; Lindley RI; Chalmers J; Anderson CS; Stroke; 2018 Jun; 49(6):1407-1411. PubMed ID: 29777016 [TBL] [Abstract][Full Text] [Related]
20. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]